|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 | |
| C07K 14/475 |
| (11) | Patento numeris | 3212226 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15855147.3 |
| Europos patento paraiškos padavimo data | 2015-10-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-09-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-03-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/058111 |
| Data | 2015-10-29 |
| (87) | Numeris | WO 2016/069921 |
| Data | 2016-05-06 |
| (30) | Numeris | Data | Šalis |
| 201462073737 P | 2014-10-31 | US | |
| 201562244604 P | 2015-10-21 | US |
| (72) |
SHEN, Wenyan, US
LINDHOUT, Darrin, US
HALDANKAR, Raj, US
MATERN, Hugo, US
|
| (73) |
NGM Biopharmaceuticals, Inc.,
333 Oyster Point Boulevard, South San Francisco, CA 94080,
US
|
| (54) | COMPOSITIONS AND METHODS OF USE FOR TREATING METABOLIC DISORDERS |
| COMPOSITIONS AND METHODS OF USE FOR TREATING METABOLIC DISORDERS |